Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Telvate-MT Tablet ER

Prescription Icon
Prescription Required

Marketer

Adivis Pharma Pvt Ltd

Salt Composition

Telmisartan (40mg) + Metoprolol Succinate (47.5mg)

Overview Telvate-MT Tablet ER

CardioTen ER tablets are prescribed for hypertension management. This medication reduces blood pressure, thereby mitigating the risk of future strokes and heart attacks. Early intervention significantly improves survival rates following a heart attack. For optimal blood levels, take CardioTen ER with meals at the same time daily, continuing as directed by your physician. Even feeling well, do not discontinue this medication independently, as hypertension is often asymptomatic; cessation may worsen your condition. Lifestyle modifications, including regular exercise, weight management, and a healthy diet, are also crucial for blood pressure control. Adhere strictly to your doctor's instructions. Common side effects include headache, weakness, dizziness, hypotension (occasionally with fainting), elevated potassium levels, shortness of breath, nausea, vomiting, abdominal pain, and fatigue. Avoid potassium-rich foods and supplements. Dizziness may occur; avoid driving and rise slowly from a seated position. Regular monitoring of blood pressure, blood sugar, kidney function, urea, and electrolyte levels may be required. Inform your doctor of any pre-existing liver or kidney conditions before starting treatment. Pregnant or breastfeeding individuals should seek medical advice before use. Disclose all other medications, particularly those for hypertension or heart conditions.

Uses of Telvate-MT Tablet ER

Managing Elevated Blood Pressure

Major Benefits of Telvate-MT Tablet ER:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Consume Telvate-MT Extended-Release Tablets with food.

Common Side effects of Telvate-MT Tablet ER:

  • Headache
  • Weakness
  • Dizziness
  • Cold extremities
  • Slow heart rate
  • Increased potassium level in blood
  • Decreased blood pressure
  • Orthostatic hypotension (sudden lowering of blood pressure on standing)
  • Breathlessness
  • Vomiting
  • Abdominal pain

How to use Telvate-MT Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Telvate-MT Tablet ER whole; avoid crushing, chewing, or breaking it. Administer this medication with a meal.

How Telvate-MT Tablet ER works:

Telmisartan and Metoprolol Succinate, combined in Telvate-MT Extended-Release Tablets, offer a dual approach to blood pressure management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Telvate-MT Tablet ER and alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Telvate-MT tablets pose a confirmed risk to a fetus and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential advantages outweigh the known dangers. Physician consultation is essential.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Extended-release Telvate-MT tablets are likely safe for breastfeeding mothers. Available human data indicates minimal risk to the infant.

DrivingDrivingUNSAFE

Extended-release Telvate-MT tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these side effects.

KidneyKidneySAFE IF PRESCRIBED

Patients with kidney disease can safely use Telvate-MT Tablet ER without requiring any alteration to the prescribed dosage.

LiverLiverCAUTION

Extended-release Telvate-MT tablets require careful administration for individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Telvate-MT Tablet ER :

Should you forget a Telvate-MT Tablet ER dose, administer it immediately if convenient. Otherwise, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Telvate-MT Tablet ER

LabelValue
Addictive None.
Type of Medication HEART

FAQs on Telvate-MT Tablet ER

Indeed, Telvate-MT Extended-Release Succinate Tablets may induce dizziness. This side effect is more likely upon standing quickly after sitting or lying down. To minimize dizziness or fainting, stand gradually after prolonged periods of sitting or recumbency.
Adopting a healthier lifestyle complements the use of Telvate-MT Tablet ER Succinate. Quitting smoking is crucial, as it significantly elevates the risk of cardiovascular events such as heart attack and stroke. Weight management is also important; individuals who are overweight or obese should strive for weight loss. A balanced diet rich in fruits and vegetables is recommended. Regular physical activity strengthens the heart and lowers the likelihood of a heart attack.
Continue taking Telvate-MT Tablet ER as directed by your physician, even if you feel healthy. Abrupt cessation of Telvate-MT Tablet ER can result in severe adverse events, including myocardial infarction and cerebrovascular accident.
Store this medication in its original, tightly sealed container or packaging. Follow the storage instructions provided on the packaging or label. Discard any remaining medication. Ensure it remains inaccessible to children, pets, and others.
Telvate-MT Tablet ER
94
MRP 115
18% off